Vaxart Inc. (VXRT)
NASDAQ: VXRT
· Real-Time Price · USD
0.42
0.02 (5.00%)
At close: May 15, 2025, 3:27 PM
Vaxart Revenue Breakdown
| Period Ending | Dec 31, 2024 | Dec 31, 2023 | Dec 31, 2022 | Dec 31, 2021 | Dec 31, 2019 | Dec 31, 2018 |
|---|---|---|---|---|---|---|
| Government Contract Revenue | 65.4M | 3.92M | 107K | n/a | -20K | 1.34M |
| Government Contract Revenue Growth | +1568.37% | +3563.55% | n/a | -100.00% | -101.49% | n/a |
| Non Cash Royalty Revenue Revenue | 3.84M | n/a | n/a | n/a | n/a | 1.48M |
| Non Cash Royalty Revenue Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | May 2, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 4.02M | 4.34M | 5.18M | 6.14M | 4.24M | 4.92M | 5.6M | 6.63M | 6.45M | 6.96M | 9.32M | 6.66M | 5.75M | 5.04M | 5.15M | 5.94M | 5.13M | 4.19M | 3.9M | 1.99M | 1.33M | 1.46M | 1.38M | 2.03M | 1.23M | 1.67M | 1.77M | 2.01M | 2.6M | 1.7M | 1.5M | 1.3M | 1.5M | 1.4M | 1M | 1.5M | 1.5M | 1.6M | 600K | 2.4M |
| Selling, General, and Administrative Revenue Growth | -7.35% | -16.13% | -15.66% | +44.76% | -13.84% | -12.09% | -15.50% | +2.76% | -7.37% | -25.33% | +40.00% | +15.71% | +14.12% | -2.10% | -13.36% | +15.96% | +22.34% | +7.55% | +95.78% | +49.51% | -8.52% | +5.82% | -32.13% | +65.25% | -26.76% | -5.48% | -11.89% | -22.69% | +52.94% | +13.33% | +15.38% | -13.33% | +7.14% | +40.00% | -33.33% | 0.00% | -6.25% | +166.67% | -75.00% | n/a |
| Research and Development Revenue | 22.65M | 15.07M | 17.48M | 19.01M | 14.71M | 15M | 18.81M | 19.62M | 20.46M | 22.47M | 19.93M | 18.2M | 15.53M | 12.41M | 10.74M | 10.07M | 8.59M | 4.62M | 5.11M | 1.54M | 3.29M | 3.71M | 3.71M | 3.83M | 4.47M | 4.38M | 5.01M | 3.41M | 2.5M | 2.8M | 3.7M | 6.8M | 10.2M | 7.6M | 5.9M | 8.5M | 6.3M | 5.5M | 5.3M | 4.8M |
| Research and Development Revenue Growth | +50.37% | -13.81% | -8.06% | +29.30% | -1.98% | -20.26% | -4.12% | -4.09% | -8.93% | +12.75% | +9.47% | +17.21% | +25.15% | +15.57% | +6.59% | +17.25% | +86.11% | -9.74% | +231.65% | -53.14% | -11.37% | +0.16% | -3.19% | -14.42% | +2.12% | -12.59% | +47.07% | +36.32% | -10.71% | -24.32% | -45.59% | -33.33% | +34.21% | +28.81% | -30.59% | +34.92% | +14.55% | +3.77% | +10.42% | n/a |